4.7 Article

Progressive Neurologic Dysfunction in a Psoriasis Patient Treated With Dimethyl Fumarate

Journal

ANNALS OF NEUROLOGY
Volume 78, Issue 4, Pages 501-514

Publisher

WILEY
DOI: 10.1002/ana.24471

Keywords

-

Funding

  1. German Cluster of Excellence Inflammation-at-Interfaces [ExC 306]
  2. Faculty of Medicine, University of Kiel, Germany
  3. NIH [NINDS R01 NS 047029, NS 074995]
  4. German Research Council [SFB 855, DE 438/14-1, DE 438/16-1, SFB 654, FOR 2093]

Ask authors/readers for more resources

Progressive multifocal leukoencephalopathy (PML) has recently been described in psoriasis or multiple sclerosis patients treated with fumaric acid esters (fumarates), who had developed severe and long-standing lymphocytopenia (<500/mm(3)). We report a psoriasis patient who presented with progressive neurologic dysfunction and seizures after 2.5 years of fumarate therapy. Despite absolute lymphocyte counts remaining between 500-1000/mm(3), his CD4(+) and CD8(+) T-cell counts were markedly low. MRI showed right hemispheric and brainstem lesions and JC virus DNA was undetectable in his cerebrospinal fluid. Brain biopsy revealed typical features of PML as well as JC virus-infected neurons. Clinicians should consider PML in the differential diagnosis of fumarate-treated patients presenting with brain lesions or seizures even in the absence of severe lymphocytopenia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available